Outset Medical
Outset Medical, Inc. develops and provides innovative dialysis technology for kidney patients in the US.
Founded
2003Outset Medical, Inc. develops and provides innovative dialysis technology for kidney patients in the US.
Outset Medical, Inc. was founded with the mission to revolutionize dialysis treatment for kidney patients through innovative technology. The company's core product, the Tablo Hemodialysis System, is designed to simplify dialysis treatment, making it more accessible and manageable for both patients and healthcare providers. Outset Medical focuses on the U.S. market, aiming to improve the quality of care in settings such as nursing homes and skilled nursing facilities (SNFs), where onsite dialysis can significantly enhance patient outcomes and reduce hospital stays.
Notable figures affiliated with Outset Medical include Dr. Charles Minn, who has highlighted the benefits of onsite dialysis in enhancing patient care. The company has attracted significant investment from prominent venture capital firms, contributing to its rapid growth and development. Key achievements include the successful implementation of the Tablo system in various healthcare settings, which has garnered positive feedback for its ease of use and effectiveness. Overall, Outset Medical has made a substantial impact on the dialysis industry by providing a more patient-centric and efficient solution for kidney care.
Companies similar to Outset Medical include Diality, Brookhaven Medical, Byonyks Medical Devices and Avenu Medical.
Outset Medical was founded in 2003.
Outset Medical's headquarters is located in San Jose, CA, US.
Outset Medical's most recent funding round was for $300M (USD) in November 2022.
As of Nov 4, 2022, Outset Medical has disclosed funding of $927M (USD). Undisclosed round amounts are excluded.
Outset Medical has 518 employees as of Feb 6, 2024.
Avenu Medical
avenumedical.com
